Panbio subsidiary wins US defence department grant
Thursday, 16 February, 2006
Panbio's (ASX:PBO) US subsidiary Panbio Inc has been awarded almost US$100,000 (AUD$135,000) in funding from the US Deparment of Defence.
The Phase I Small Business Innovation Research grant will fund the development of a multiplex assay for agents of infectious disease based on Panbio's patented Oligo Rapid lateral flow technology which will enable testing for multiple disease states from a single disposable device.
If Maryland-based Panbio Inc successfully completes the research for the grant, the company can bid for a Phase 2 grant, valued up to US$750,000.
Liquid fat treatment provides hope for rare childhood disease
A liquid fat supplement, triheptanoin, can reverse mitochondrial dysfunction and cell death in...
NSW Govt delivers foot-and-mouth vaccine to protect livestock
A biodegradable vaccine to protect livestock from foot-and-mouth disease has been developed as...
Scientists optimise delivery of mRNA to target cells
A highly versatile new method captures and attaches antibodies to the surface of mRNA-loaded...
